{"DataElement":{"publicId":"2760894","version":"1","preferredName":"Lung Disorder Diagnosis Type","preferredDefinition":"A description of the lung disorder diagnosis type.","longName":"2760886v1.0:2760888v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2760886","version":"1","preferredName":"Lung Disorder Diagnosis","preferredDefinition":"A non-neoplastic or neoplastic condition affecting the lung.  Representative examples of non-neoplastic conditions include chronic obstructive pulmonary disease and pneumonia.  Representative examples of neoplastic conditions include benign processes (e.g., respiratory papilloma) and malignant processes (e.g., lung carcinoma and metastatic cancer to the lung)._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","longName":"LNG_DIAG","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2970303","version":"1","preferredName":"Lung Disorder","preferredDefinition":"A non-neoplastic or neoplastic condition affecting the lung.  Representative examples of non-neoplastic conditions include chronic obstructive pulmonary disease and pneumonia.  Representative examples of neoplastic conditions include benign processes (e.g., respiratory papilloma) and malignant processes (e.g., lung carcinoma and metastatic cancer to the lung).","longName":"C3198","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Disorder","conceptCode":"C3198","definition":"A non-neoplastic or neoplastic disorder affecting the lung. Representative examples of non-neoplastic disorders include chronic obstructive pulmonary disease and pneumonia. Representative examples of neoplastic disorders include benign processes (e.g., respiratory papilloma) and malignant processes (e.g., lung carcinoma and metastatic cancer to the lung).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7AE258D5-772E-A945-E040-BB89AD437B5C","latestVersionIndicator":"Yes","beginDate":"2009-12-16","endDate":null,"createdBy":"WHITES","dateCreated":"2009-12-16","modifiedBy":"ONEDATA","dateModified":"2009-12-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2239981","version":"1","preferredName":"Diagnosis","preferredDefinition":"The process of identifying a disease by the signs and symptoms.","longName":"C15220","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FD4EEB-1C71-0B27-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-26","modifiedBy":"ONEDATA","dateModified":"2005-06-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"50703EF2-A4E0-0DC3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-24","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-06-24","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2760888","version":"1","preferredName":"Lung Disorder Diagnosis Type","preferredDefinition":"A non-neoplastic or neoplastic condition affecting the lung.  Representative examples of non-neoplastic conditions include chronic obstructive pulmonary disease and pneumonia.  Representative examples of neoplastic conditions include benign processes (e.g., respiratory papilloma) and malignant processes (e.g., lung carcinoma and metastatic cancer to the lung)._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation._Type; a subdivision of a particular kind of thing.","longName":"LNG_DX_TYP","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2567790","version":"1","preferredName":"Other","longName":"2567790","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D5DB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"KUMMEROA","dateModified":"2023-11-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"506F91C9-5321-1614-E044-0003BA3F9857","beginDate":"2008-06-24","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-06-24","modifiedBy":"CZECHS","dateModified":"2008-06-24","deletedIndicator":"No"},{"value":"Carbon monoxide diffusing capacity(DLco) less than 50%","valueDescription":"Less Than Integer::50 Percentage Decreased Carbon Monoxide Diffusing Capacity","ValueMeaning":{"publicId":"3029077","version":"1","preferredName":"Less Than Integer::50 Percentage Decreased Carbon Monoxide Diffusing Capacity","longName":"3029077","preferredDefinition":"A statement about the relative size or order of two objects specifying that an object of interest is smaller than another object in quantity or measure or value or status.: A number with no fractional part.::50: Percentage; a fraction or ratio with 100 understood as the denominator.: A lung function test result in which the lung capacity to absorb carbon monoxide is decreased.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Less Than","conceptCode":"C61585","definition":"A statement about the relative size or order of two objects specifying that an object of interest is smaller than another object in quantity or measure or value or status.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Integer","conceptCode":"C45255","definition":"A number with no fractional part, including the negative and positive numbers as well as zero.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Percentage","conceptCode":"C25613","definition":"A fraction or ratio with 100 understood as the denominator.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Decreased Carbon Monoxide Diffusing Capacity","conceptCode":"C78229","definition":"A lung function test result in which the lung capacity to absorb carbon monoxide is decreased.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"827B1D41-DD5F-1890-E040-BB89AD437289","latestVersionIndicator":"Yes","beginDate":"2010-03-23","endDate":null,"createdBy":"LOHNESC","dateCreated":"2010-03-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"827B1D41-DD78-1890-E040-BB89AD437289","beginDate":"2008-06-24","endDate":null,"createdBy":"LOHNESC","dateCreated":"2010-03-23","modifiedBy":"ONEDATA","dateModified":"2010-03-23","deletedIndicator":"No"},{"value":"Asthma / reactive airway disease","valueDescription":"Asthma And/Or Reaction Respiratory System Disease or Disorder","ValueMeaning":{"publicId":"3108378","version":"1","preferredName":"Asthma And/Or Reaction Respiratory System Disease or Disorder","longName":"3108378","preferredDefinition":"A chronic respiratory disease manifested as difficulty breathing due to the narrowing of bronchial passageways.: Used to indicate that either or both of two items or options: Reaction; a bodily process occurring due to the effect of some foregoing stimulus or agent.: (RES-pih-ra-tor-ee) The organs that are involved in breathing. These include the nose, throat, larynx, trachea, bronchi, and lungs.Also known as the respiratory tract.: Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Asthma","conceptCode":"C28397","definition":"A chronic respiratory disease manifested as difficulty breathing due to the narrowing of bronchial passageways.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Reaction","conceptCode":"C25637","definition":"A response generated by a stimulus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Respiratory System","conceptCode":"C12779","definition":"The organs involved in the exchange of carbon dioxide and oxygen including the trachea, bronchi, and lung parenchyma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"88891E4B-7B48-87CE-E040-BB89AD432BAE","latestVersionIndicator":"Yes","beginDate":"2010-06-08","endDate":null,"createdBy":"WHITES","dateCreated":"2010-06-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","id":"88891E4B-7B61-87CE-E040-BB89AD432BAE","beginDate":"2008-06-24","endDate":null,"createdBy":"WHITES","dateCreated":"2010-06-08","modifiedBy":"ONEDATA","dateModified":"2010-06-08","deletedIndicator":"No"},{"value":"Chronic obstructive pulmonary disease","valueDescription":"Chronic Obstructive Airways Disease","ValueMeaning":{"publicId":"2573574","version":"1","preferredName":"Chronic Obstructive Airways Disease","longName":"2573574","preferredDefinition":"A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Obstructive Pulmonary Disease","conceptCode":"C3199","definition":"A chronic and progressive lung disorder characterized by the loss of elasticity of the bronchial tree and the air sacs, destruction of the air sacs wall, thickening of the bronchial wall, and mucous accumulation in the bronchial tree. The pathologic changes result in the disruption of the air flow in the bronchial airways. Signs and symptoms include shortness of breath, wheezing, productive cough, and chest tightness. The two main types of chronic obstructive pulmonary disease are chronic obstructive bronchitis and emphysema.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EC73-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-03-15","modifiedBy":"CZECHS","dateModified":"2008-06-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"88891E4B-7BDC-87CE-E040-BB89AD432BAE","beginDate":"2008-06-24","endDate":null,"createdBy":"WHITES","dateCreated":"2010-06-08","modifiedBy":"ONEDATA","dateModified":"2010-06-08","deletedIndicator":"No"},{"value":"Restrictive lung disease","valueDescription":"Restriction Lung Disorder","ValueMeaning":{"publicId":"3108381","version":"1","preferredName":"Restriction Lung Disorder","longName":"3108381","preferredDefinition":"Anything that limits; a limitation.: A non-neoplastic or neoplastic condition affecting the lung.  Representative examples of non-neoplastic conditions include chronic obstructive pulmonary disease and pneumonia.  Representative examples of neoplastic conditions include benign processes (e.g., respiratory papilloma) and malignant processes (e.g., lung carcinoma and metastatic cancer to the lung).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Restriction","conceptCode":"C53452","definition":"Anything that limits; a limitation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Lung Disorder","conceptCode":"C3198","definition":"A non-neoplastic or neoplastic disorder affecting the lung. Representative examples of non-neoplastic disorders include chronic obstructive pulmonary disease and pneumonia. Representative examples of neoplastic disorders include benign processes (e.g., respiratory papilloma) and malignant processes (e.g., lung carcinoma and metastatic cancer to the lung).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"88891E4B-7BE9-87CE-E040-BB89AD432BAE","latestVersionIndicator":"Yes","beginDate":"2010-06-08","endDate":null,"createdBy":"WHITES","dateCreated":"2010-06-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"88891E4B-7C02-87CE-E040-BB89AD432BAE","beginDate":"2008-06-24","endDate":null,"createdBy":"WHITES","dateCreated":"2010-06-08","modifiedBy":"ONEDATA","dateModified":"2010-06-08","deletedIndicator":"No"},{"value":"Pulmonary fibrosis","valueDescription":"Pulmonary Fibrosis","ValueMeaning":{"publicId":"2946061","version":"1","preferredName":"Pulmonary Fibrosis","longName":"2946061","preferredDefinition":"Chronic progressive interstitial lung disorder characterized by the replacement of the lung tissue by connective tissue, leading to progressive dyspnea, respiratory failure, or right heart failure. Causes include chronic inflammatory processes, exposure to environmental irritants, radiation therapy, autoimmune disorders, certain drugs, or it may be idiopathic (no identifiable cause).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pulmonary Fibrosis","conceptCode":"C26869","definition":"Chronic progressive interstitial lung disorder characterized by the replacement of the lung tissue by connective tissue, leading to progressive dyspnea, respiratory failure, or right heart failure. Causes include chronic inflammatory processes, exposure to environmental irritants, radiation therapy, autoimmune disorders, certain drugs, or it may be idiopathic (no identifiable cause).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746AE5AE-64F0-370C-E040-BB89AD4351E3","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B25DD540-55A2-5DF6-E053-4EBD850A6B22","beginDate":"2020-10-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-10-23","modifiedBy":"ONEDATA","dateModified":"2020-10-23","deletedIndicator":"No"},{"value":"Bronchopulmonary dysplasia","valueDescription":"Bronchopulmonary Dysplasia","ValueMeaning":{"publicId":"7479168","version":"1","preferredName":"Bronchopulmonary Dysplasia","longName":"7479168","preferredDefinition":"Chronic lung disease requiring treatment with oxygen for at least 28 days and with a spectrum of severity from mild to severe, that predominantly affects premature infants. While the radiologic pattern is typical in the closer to term patient, the pattern in the small preterm infant is very non-discrete and variable.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bronchopulmonary Dysplasia","conceptCode":"C90599","definition":"Chronic lung disease requiring treatment with oxygen for at least 28 days and with a spectrum of severity from mild to severe, that predominantly affects premature infants. While the radiologic pattern is typical in the closer to term patient, the pattern in the small preterm infant is very non-discrete and variable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B25DD540-55AF-5DF6-E053-4EBD850A6B22","latestVersionIndicator":"Yes","beginDate":"2020-10-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-10-23","modifiedBy":"ONEDATA","dateModified":"2020-10-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B25DD540-55C8-5DF6-E053-4EBD850A6B22","beginDate":"2020-10-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-10-23","modifiedBy":"ONEDATA","dateModified":"2020-10-23","deletedIndicator":"No"},{"value":"Asthma","valueDescription":"Asthma","ValueMeaning":{"publicId":"2975594","version":"1","preferredName":"Asthma","longName":"2975594","preferredDefinition":"A chronic respiratory disease manifested as difficulty breathing due to the narrowing of bronchial passageways.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Asthma","conceptCode":"C28397","definition":"A chronic respiratory disease manifested as difficulty breathing due to the narrowing of bronchial passageways.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C08420A-B206-2A47-E040-BB89AD433D97","latestVersionIndicator":"Yes","beginDate":"2009-12-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B25DD540-55D2-5DF6-E053-4EBD850A6B22","beginDate":"2020-10-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-10-23","modifiedBy":"ONEDATA","dateModified":"2020-10-23","deletedIndicator":"No"},{"value":"Bronchiectasis","valueDescription":"Bronchiectasis","ValueMeaning":{"publicId":"3210737","version":"1","preferredName":"Bronchiectasis","longName":"3210737","preferredDefinition":"Segmental, irreversible dilation of the bronchial tree resulting in the accumulation of secretions which leads to obstruction. The most common cause is bacterial infection.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bronchiectasis","conceptCode":"C84475","definition":"Segmental, irreversible dilation of the bronchial tree resulting in the accumulation of secretions which leads to obstruction. The most common cause is bacterial infection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-9714-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B25DD540-55DC-5DF6-E053-4EBD850A6B22","beginDate":"2020-10-23","endDate":null,"createdBy":"MALUMK","dateCreated":"2020-10-23","modifiedBy":"ONEDATA","dateModified":"2020-10-23","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2970304","version":"1","preferredName":"Lung Disorder Diagnosis Type","preferredDefinition":"A non-neoplastic or neoplastic condition affecting the lung.  Representative examples of non-neoplastic conditions include chronic obstructive pulmonary disease and pneumonia.  Representative examples of neoplastic conditions include benign processes (e.g., respiratory papilloma) and malignant processes (e.g., lung carcinoma and metastatic cancer to the lung).:The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.:Type; a subdivision of a particular kind of thing.","longName":"C3198:C15220:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Disorder","conceptCode":"C3198","definition":"A non-neoplastic or neoplastic disorder affecting the lung. Representative examples of non-neoplastic disorders include chronic obstructive pulmonary disease and pneumonia. Representative examples of neoplastic disorders include benign processes (e.g., respiratory papilloma) and malignant processes (e.g., lung carcinoma and metastatic cancer to the lung).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7AE258D5-7747-A945-E040-BB89AD437B5C","latestVersionIndicator":"Yes","beginDate":"2009-12-16","endDate":null,"createdBy":"WHITES","dateCreated":"2009-12-16","modifiedBy":"ONEDATA","dateModified":"2009-12-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"506F91C9-5279-1614-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-24","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-06-24","modifiedBy":"MALUMK","dateModified":"2020-10-23","changeDescription":".Added PVs for F4000r7. 10/23/2020 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964872","version":"1","longName":"2000r1: Recipient Baseline Data","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"PerformedDiagnosis:value","type":"HCT_BRIDG","context":"NHLBI"},{"name":"CPRE_ICT_pulmonary_dis_type","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What is the pulmonary diagnos","type":"Preferred Question Text","description":"What is the pulmonary diagnosis type?","url":null,"context":"NHLBI"},{"name":"Specify diagnosis:","type":"Alternate Question Text","description":"Specify diagnosis:","url":null,"context":"NHLBI"},{"name":"BRIDG mapping path for CDE:2760894","type":"BRIDG Mapping Path","description":"PerformedDiagnosis [first] > AssessedResultRelationship > PerformedObservation > PerformedDiagnosis.value [second] WHERE PerformedDiagnosis.value [first] = \"Lung Disorder\"","url":null,"context":"NHLBI"},{"name":"Specify pulmonary disease","type":"Application Standard Question Text","description":"Specify pulmonary disease","url":null,"context":"NHLBI"},{"name":"Specify pulmonary disease","type":"Alternate Question Text","description":"Specify pulmonary disease","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"506F91C9-5366-1614-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-06-24","endDate":null,"createdBy":"CZECHS","dateCreated":"2008-06-24","modifiedBy":"MALUMK","dateModified":"2021-01-28","changeDescription":".Added AQT. 10/23/2020 KMM. System generated def displayed as alt def. 12/15/2020 KMM. Added ALT name. 01/28/2021 KMM","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}